Dr. Feldman is a pulmonologist, intensivist, and health services researcher at Harvard Medical School and Brigham and Women's Hospital, where he has joint appointments in the Division of Pharmacoepidemiology and Pharmacoeconomics and the Division of Pulmonary and Critical Care Medicine. He completed his undergraduate degree in philosophy at Duke University, his medical degree at the University of California San Francisco, his doctorate in political theory at the University of Oxford, and his master's in public health at the Harvard TH Chan School of Public Health. He was a Fulbright Scholar at the University of Haifa and a Zuckerman fellow at the Center for Public Leadership at Harvard Kennedy School. He completed training in Internal Medicine and Pulmonary and Critical Care Medicine at Brigham and Women's Hospital.
Dr. Feldman's research focuses on drug pricing, FDA regulation, pharmaceutical policy, and COPD outcomes. His work has appeared in the New England Journal of Medicine, the Journal of the American Medical Association, Health Affairs, and Lancet Respiratory Medicine. He currently serves as Co-Chair of the Ethics Committee and Associate Director of the Ethics Service at Brigham and Women's Hospital.